Your browser doesn't support javascript.
loading
In vitro activity of imipenem-relebactam alone and in combination with fosfomycin against carbapenem-resistant gram-negative pathogens.
Xu, Chunquan; Chen, Tao; Zhang, Siqin; Zhou, Cui; Liao, Wenli; Fang, Renchi; Chen, Lijiang; Zhou, Tieli.
Afiliação
  • Xu C; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Chen T; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhang S; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhou C; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Liao W; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Fang R; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Chen L; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhou T; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: wyztli@163.com.
Diagn Microbiol Infect Dis ; 103(3): 115712, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35613493

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enterobacteriáceas Resistentes a Carbapenêmicos / Fosfomicina Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enterobacteriáceas Resistentes a Carbapenêmicos / Fosfomicina Idioma: En Ano de publicação: 2022 Tipo de documento: Article